Composition
- Active ingredients
- OXYBUTYNIN 3.9MG/24HR
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA090526.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Oxybutynin
- Route
- Transdermal
- Dosage form
- Film, extended release
- Applicant
- Barr Labs Div Teva
- Status
- Discontinued
- FDA approval
- 4 Mar 2014
- Application
- ANDA090526-001